Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Long-Acting Rilpivirine (TMC278LA) PrEP in HIV-Negative Volunteers
NCT01049932Phase 2Terminated
- Sponsor
- St Stephen's AIDS Trust
- Start
- Mar 2010
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rilpivirine in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Started Mar 2010; status: terminated.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01049932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01049932.